C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/227, 260/273
C07D 513/04 (2006.01) A61K 31/435 (2006.01) C07D 215/30 (2006.01)
Patent
CA 1287356
ABSTRACT OF THE DISCLOSURE Trans-(?)-2,5-optionally substituted- octahydrothiazolo [4,5-g] quinolines, or their enantiomers, of the formula Image I wherein R is H, benzyl, methyl, ethyl, n-propyl or allyl; R1 is H, OH, halogen,methyl, NH2, NHC1-3 alkyl, N(C1-3 alkyl)2, 1-pyrrolidinyl, NHCOC1-3 alkyl, or NHC1-2 alkylphenyl; or their pharmaceutically acceptable acid addition or quaternary salts thereof, are provided by the present invention. As D-2 dopamine agonists, the compounds of this invention are useful in treating Parkinson's Syndrome, in treating sexual dysfunction, as antidepressants and anti-anxiety agents in lowering blood pressure in hypertensive animals, and in inhibiting prolactin secretion.
479702
Kornfeld Edmund C.
Titus Robert D.
Eli Lilly And Company
Gowling Lafleur Henderson Llp
Kornfeld Edmund C.
Titus Robert D.
LandOfFree
Octahydrothiazolo¬4,5-q|quinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Octahydrothiazolo¬4,5-q|quinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Octahydrothiazolo¬4,5-q|quinolines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1305200